Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disordersFabrizio Michetti, Francesco Ria, Patrizia Casalbore et al.|Neuroscience & Biobehavioral Reviews|2021Cited by 58
The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing—Remitting Multiple Sclerosis Mouse ModelGabriele Di Sante, Fabrizio Michetti, Susanna Amadio et al.|Cells|2020Cited by 32
S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune EncephalomyelitisChiara Camponeschi, Gabriele Di Sante, Maria De Carluccio et al.|International Journal of Molecular Sciences|2021Cited by 25